SREBP-2 and SCAP isoforms and risk of early onset myocardial infarction

Atherosclerosis

Volumn 196, Issue 2, 2008, Pages 896-904

  Friedlander, Yechiel ^a   Schwartz, Stephen M ^b,c   Durst, Ronen ^a   Meiner, Vardiella ^a   Robertson, Andrea S ^b   Erez, Gilli ^a   Leitersdorf, Eran ^a   Siscovick, David S ^b,c  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Early onset; Gene gene interaction; Genetic polymorphism; Myocardial infarction; SCAP; SREBP

Indexed keywords

PROTEIN; SREBP CLEAVAGE ACTIVATING PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; RACE DIFFERENCE; STROKE;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; PROTEIN ISOFORMS; RISK; STEROL REGULATORY ELEMENT BINDING PROTEIN 2;

EID: 38549134970     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.02.006     Document Type: Article

References (22)

1. Sakai J., Nohturfft A., Cheng D., Ho Y.K., Brown M.S., and Goldstein J.L. Identification of complexes between the COOH-terminal domains of sterol regulatory element-binding proteins (SREBPs) and SREBP cleavage-activating protein. J Biol Chem 272 (1997) 20213-20221
2. Brown M.S., and Goldstein J.L. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci 96 (1999) 11041-11048
3. Miserez A.R., Muller P.Y., Barella L., et al. Sterol-regulatory element-binding protein (SREBP)-2 contributes to polygenic hypercholesterolaemia. Atherosclerosis 164 (2002) 15-26
4. Iwaki K., Nakajima T., Ota N., and Emi M. A common Ile796Val polymorphism of the human SREBP cleavage-activating protein (SCAP) gene. J Hum Genet 44 (1999) 421-422
5. Vedie B., Jeunemaitre X., Megnien J.L., Atger V., Simon A., and Moatti N. A new DNA polymorphism in the 5′ untranslated region of the human SREBP-1a is related to development of atherosclerosis in high cardiovascular risk population. Atherosclerosis 154 (2001) 589-597
6. Salek L., Lutucuta S., Ballantyne C.M., Gotto Jr. A.M., and Marian A.J. Effects of SREBF-1a and SCAP polymorphisms on plasma levels of lipids, severity, progression and regression of coronary atherosclerosis and response to therapy with fluvastatin. J Mol Med 80 (2002) 737-744
7. Fiegenbaum M., Silveira F.R., Van-der Sand C.R., et al. Determinants of variable response to simvastatin treatment: the role of common variants of SCAP, SREBF-1a and SREBF-2 genes. Pharmacogenomics J 5 (2005) 359-364
8. Ives D.G., Fitzpatrick A.L., Bild D.E., et al. Ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol 5 (1995) 278-285
9. Hainline Jr. A., Miller D.T., and Mather A. The Coronary Drug Project. Role and methods of the Central Laboratory. Control Clin Trials 4 (1983) 377-387
10. Marcovina S.M., Koschinsky M.L., Albers J.J., and Skarlatos S. Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: recent advances and future directions. Clin Chem 49 (2003) 1785-1796
11. Hosmer D.W., and Lemeshow S. Confidence interval estination of interaction. Epidemiology 3 (1992) 452-456
12. Robinet P., Vedie B., Chironi G., et al. Characterization of polymorphic structure of SREBP-2 gene: role in atherosclerosis. Atherosclerosis 168 (2003) 381-387
13. Muller P.Y., and Miserez A.R. Identification of mutations in the gene encoding sterol regulatory element binding protein (SREBP)-2 in hypercholesterolaemic subjects. J Med Genet 39 (2002) 271-275
14. Takada D., Emi M., Ezura Y., et al. Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: molecular study in a 1135-member familial hypercholesterolemia kindred. J Hum Genet 47 (2002) 656-664
15. Horton J.D., Shimomura I., Ikemoto S., Bashmakov Y., and Hammer R.E. Overexpression of sterol regulatory element-binding protein-1a in mouse adipose tissue produces adipocyte hypertrophy, increased fatty acid secretion, and fatty liver. J Biol Chem 278 (2003) 36652-36660
16. Kan H.Y., Pissios P., Chambaz J., and Zannis V.I. DNA binding specificity and transactivation properties of SREBP-2 bound to multiple sites on the human apoA-II promoter. Nucl Acids Res 27 (1999) 1104-1117
17. Le-Lay S., Krief S., Farnier C., et al. Cholesterol, a cell size-dependent signal that regulates glucose metabolism and gene expression in adipocytes. J Biol Chem 276 (2001) 16904-16910
18. Fan Y.-M., Laaksonen R., Janatuinen T., et al. Effects of pravastatin therapy on serum lipids and coronary reactivity are not associated with SREBP cleavage-activating protein polymorphism in healthy young men. Clin Genet 60 (2001) 319-321
19. Rios D.L.S., Vargas A.F., Torres M.R., Zago A.J., Callegari-Jacques S.M., and Hutz S.M. Interaction between SREBP-1a and APOB polymorphisms influences total and low-density lipoprotein cholesterol levels in patients with coronary artery disease. Clin Genet 63 (2003) 380-385
20. Durst R., Jansen A., Erez G., et al. The discrete and combined effect of SREBP-2 and SCAP isoforms in the control of plasma lipids among familial hypercholesterolaemia patients. Atherosclerosis 189 (2006) 443-450
21. Neer E.J., Schmidt C.J., Nambudripad R., and Smith T.F. The ancient regulatory-protein family of WD-repeat proteins. Nature 371 (1994) 297-300
22. Brown M.S., and Goldstein J.L. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89 (1997) 331-340